SBC Medical Group Holdings
SBC · NASDAQ
About SBC
- Employees
- 863
- Headquarters
- Irvine, California
- Listed
- Sep 26, 2022
- Sector
- Health Care
- Industry
- Health Care Providers & Services
- Website
- ir.sbc-holdings.com
SBC key statistics
- Market cap
- 561.54M
- Price-earnings ratio
- 11.40
- Dividend yield
- —
- Average volume
- 201.10K
- Volume
- 170.80K
- Open price
- $5.35
- High today
- $5.48
- Low today
- $5.28
- 52 Week high
- $5.61
- 52 Week low
- $2.78
SBC Medical Group Holdings (SBC) at a glance
As of Oct 20, 2026, SBC Medical Group Holdings (SBC) shares are priced at $5.46, giving the company a market cap of 561.54M and a price-to-earnings ratio of 11.40.
Today the stock has traded between $5.28 and $5.48. The current price is 3.4% above the day's low and 0.4% below its high.
Volume so far is 170.80K shares, in line with the average of 201.10K shares a day.
Over the past year SBC Medical Group Holdings has ranged from $2.78 to $5.61, and now sits 95% of the way up that range.
SBC Medical Group Holdings met or beat analyst EPS estimates in 5 of the last 8 quarters. In Q2 FY26 it reported $0.109 per share against an estimate of $0.1172.
The average analyst price target is $8.93, 63.5% above the current price, from 1 recent ratings.
Analyst ratings
Latest rating from each analyst over the past 12 months
- Buy100.0%
- Hold0.0%
- Sell0.0%
- Low
- $7.07
- Now
- $5.46
- High
- $11.55
SBC earnings
Earnings per share, reported against the analyst estimate
Beat the estimate in 5 of the last 8 quarters, by 26.9% on average.
- Q3 FY24: reported $0.03 per share against an estimate of $2.38
- Q4 FY24: reported $0.19 per share against an estimate of $0.1717
- Q1 FY25: reported $0.21 per share against an estimate of $0.1111
- Q2 FY25: reported $0.02 per share against an estimate of $0.1364
- Q3 FY25: reported $0.12 per share against an estimate of $0.1111
- Q4 FY25: reported $0.14 per share against an estimate of $0.1212
- Q1 FY26: reported $0.11 per share against an estimate of $0.099
- Q2 FY26: reported $0.109 per share against an estimate of $0.1172
SBC news
- Press releaseBusiness Wire
- Press releaseBusiness Wire
SBC Medical Group Holdings Reports Second Quarter 2026 Financial Results
- Press releaseBusiness Wire
SBC Medical Group Holdings Announces First Quarter 2026 Financial Results
- Press releaseBusiness Wire
SBC Medical Announces Closing of Previously Announced Secondary Public Offering of 3.1 million shares of Common Stock
- Avi Kapoor
AST SpaceMobile, SBC Medical Group And Other Big Stocks Moving Lower In Monday's Pre-Market Session
- Press releaseBusiness Wire
SBC Medical Announces Pricing of Secondary Public Offering of 3.1 Million Shares of Common Stock
- Press releaseBusiness Wire
SBC Medical Announces Fourth Quarter and Full Year 2025 Financial Results
- Press releaseBusiness Wire
SBC Medical Announces Next-Generation Wellness Strategy "SBC Wellness 2.0"
Similar companies
Companies in the same industry as SBC Medical Group Holdings
Most active stocks
Highest trading volume today
- EARIEntertainment Arts Research$0.0003−16.67%
- SEIISharing Economy International$0.0004+100.00%
- NWGLCL Workshop Group$0.1522+27.90%
- TMSHTrans Global Assets$0.0002+0.00%
- AEFIAmerican EcoFuels$0.0007+0.00%
- CBDW1606$0.0002+0.00%
- FITYFifty 1 Labs$0.0001−66.67%
- PRSOPeraso$0.5914+54.13%
- SDSTStardust Power$0.02−23.66%
- SHFSSHF Holdings$0.0899−4.36%
- FRTTFort Technology$0.7121+32.63%
- CBDLCBD Life Sciences$0.0002−25.00%
Newly listed
Companies that went public in the past six weeks
- TCXBTCGX Acquisition Corp. II$10.56+1.54%
- CTYCITY THERAPEUTICS$20.83−2.94%
- IAMIambic Therapeutics$16.01−2.02%
- AMROAmaero$5.68+1.25%
- FLSCFrazier Life Sciences Acquisition Corp. II$10.28−0.10%
- TRXBTRex Bio$14.44−2.43%
- RTSNRetension Pharmaceuticals$16.18−0.92%
- PAXGUPine Tree Acquisition$9.98+0.00%
- PORTUSouthport Acquisition Corp. IIListed Oct 1, 2026
- CHWMChilwa Minerals$5.18+3.39%
- ACCVAccelevation Holdings$12.31−1.44%
- RZAIROZE AI$10.28+1.28%
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.